Global Optic Nerve Disorder Treatment Market Report By Treatment Type (Pharmacological Treatment (Prostaglandin, Beta Interferons, Beta Blockers, Alpha-adrenergic Agonist, Carbonic Anhydrase Inhibitors, Corticosteroids, Combination Drugs, and Others), and Surgery), By Indication (Glaucoma, Optic Neuritis, Optic Neuropathy (Arteritic Ischemic Optic Neuropathy, Non-arteritic Ischemic Optic Neuropathy, and Congenital Optic Atrophy), and Others), By End User (Hospitals, Ambulatory Surgery Centers, Clinics, and Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Optic Nerve Disorders Treatment Market Report
Brand: Value Market Research
SKU: Healthcare
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11212603

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Optic Nerve Disorder Treatment Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.

Optic nerve is the bundle of nerves which cater the role of transferring the visual information to the brain through electrical impulses. Genetic or trauma related damage to this nerves lead to serious optic disorder which may lead to partial or complete blindness. Congenital Optic Atrophy, Optic Nerve Hypoplasia, glaucoma, Optic neuritis, Neuromyelitis optica are some of the common optic nerve disorders. These damages can be treated through eye drops, oral medical and for some cases laser treatment and drainage tubes surgery acts as effective treatments

Market Dynamics

Sharp rise in the nerve disorders such as multiple sclerosis (MS), glaucoma and optic neuritis is driving the demand optic nerve disorder treatment. The National Eye Institute, total cases of glaucoma is projected to reach 6.3 million by 2050 in US alone. Rising aged population worldwide with higher prevalence of blinding in the elderly population created higher need for optic nerve disorder treatment market. Ongoing R&D programs in the key companies with increase in FDA approvals for the treatment of optic nerve disorders promotes growth of this market.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of optic nerve disorder treatment.

Market Segmentation

The entire optic nerve disorder treatment market has been sub-categorized into treatment type, indication, and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Treatment Type

Pharmacological Treatment
- Prostaglandin
- Beta Interferons
- Beta Blockers
- Alpha-adrenergic Agonist
- Carbonic Anhydrase Inhibitors
- Corticosteroids
- Combination Drugs
- Others
Surgery

By Indication

Glaucoma
Optic Neuritis
Optic Neuropathy
- Arteritic Ischemic Optic Neuropathy
- Non-arteritic Ischemic Optic Neuropathy
- Congenital Optic Atrophy
Others

By End User

Hospitals
Ambulatory Surgery Centers
Clinics
Others

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for optic nerve disorder treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Optic Nerve Disorders Treatment Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the optic nerve disorder treatment market include Santen Pharmaceutical Co., Ltd., Allergan plc., Novartis AG, Pfizer, Inc., Bausch Health Companies, Inc., Aerie Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Bionure Farma, S.L. and Mallinckrodt Pharmaceuticals. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Optic Nerve Disorder Treatment Market
       2.2. Global Optic Nerve Disorder Treatment Market Snapshot

3 . OPTIC NERVE DISORDER TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Optic Nerve Disorder Treatment Market
       3.3. Market Restraints of Optic Nerve Disorder Treatment Market
       3.4. Opportunities of Optic Nerve Disorder Treatment Market
       3.5. Trends of Optic Nerve Disorder Treatment Market
       3.6. Porter’s Five Force Analysis of Optic Nerve Disorder Treatment Market
       3.7. Optic Nerve Disorder Treatment Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Treatment Type
           3.7.2 Market Attractive Analysis by Indication
           3.7.3 Market Attractive Analysis by End User
           3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Optic Nerve Disorder Treatment Value Chain Analysis
       4.2. Optic Nerve Disorder Treatment Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Optic Nerve Disorder Treatment Raw Material Manufactures List
           4.2.3. Price Trend of Optic Nerve Disorder Treatment Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Optic Nerve Disorder Treatment Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Optic Nerve Disorder Treatment Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Optic Nerve Disorder Treatment Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Optic Nerve Disorder Treatment Market

6 . GLOBAL OPTIC NERVE DISORDER TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
       6.1 Overview by Treatment Type
       6.2 Global Optic Nerve Disorder Treatment Market Analysis by Treatment Type
       6.3 Market Analysis of Pharmacological Treatment by Regions
       6.4 Market Analysis of Surgery by Regions

7 . GLOBAL OPTIC NERVE DISORDER TREATMENT MARKET ANALYSIS BY INDICATION
       7.1 Overview by Indication
       7.2 Global Optic Nerve Disorder Treatment Market Analysis by Indication
       7.3 Market Analysis of Glaucoma by Regions
       7.4 Market Analysis of Optic Neuritis by Regions
       7.5 Market Analysis of Optic Neuropathy by Regions
       7.6 Market Analysis of Others by Regions

8 . GLOBAL OPTIC NERVE DISORDER TREATMENT MARKET ANALYSIS BY END USER
       8.1 Overview by End User
       8.2 Global Optic Nerve Disorder Treatment Market Analysis by End User
       8.3 Market Analysis of Hospitals by Regions
       8.4 Market Analysis of Ambulatory Surgery Centers by Regions
       8.5 Market Analysis of Clinics by Regions
       8.6 Market Analysis of Others by Regions

9 . GLOBAL OPTIC NERVE DISORDER TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview
           9.3.2. North America Optic Nerve Disorder Treatment Market Estimate by Country
           9.3.3. United State
           9.3.4. Rest of North America
       9.4. Europe
           9.4.1. Overview
           9.4.2. Europe Optic Nerve Disorder Treatment Market Estimate by Market Segment
           9.4.3. Europe Optic Nerve Disorder Treatment Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7 Rest of Europe
       9.5. Asia Pacific
           9.5.1. Overview
           9.5.2. Asia Pacific Optic Nerve Disorder Treatment Market Estimate by Market Segment
           9.5.3. Asia Pacific Optic Nerve Disorder Treatment Market Estimate by Country
           9.5.4. China
           9.5.5. Japan
           9.5.6. India
           9.5.7. Rest of Asia Pacific
       9.6. Latin America
           9.6.1. Overview
           9.6.2. Latin America Optic Nerve Disorder Treatment Market Estimate by Market Segment
           9.6.3. Latin America Optic Nerve Disorder Treatment Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview
           9.7.2. Middle East & Africa Optic Nerve Disorder Treatment Market Estimate by Market Segment
           9.7.3. Middle East & Africa Optic Nerve Disorder Treatment Market Estimate by Country
           9.7.4. Middle East
           9.7.5. Africa

10 . COMPETITIVE LANDSCAPE OF THE OPTIC NERVE DISORDER TREATMENT COMPANIES
       10.1. Optic Nerve Disorder Treatment Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments

11 . COMPANY PROFILES OF OPTIC NERVE DISORDER TREATMENT INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Santen Pharmaceutical Co., Ltd.
           11.3.1. Company Overview
           11.3.2. Financials
          11.3.3. Products
           11.3.4. Recent Developments
       11.4. Allergan plc
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Novartis AG
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Pfizer, Inc.
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Bausch Health Companies, Inc.
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Aerie Pharmaceuticals, Inc.
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Teva Pharmaceutical Industries Ltd.
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Bionure Farma, S.L.
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Mallinckrodt Pharmaceuticals
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments

*Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Optic Nerve Disorder Treatment Report
Market Research Process
Market Research Methodology
Global Optic Nerve Disorder Treatment Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Treatment Type
Market Attractiveness Analysis by Indication
Market Attractiveness Analysis by End User
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Optic Nerve Disorder Treatment Market Analysis by Treatment Type (USD MN)
Global Optic Nerve Disorder Treatment Market Analysis in Pharmacological Treatment by Geography (USD MN)
Global Optic Nerve Disorder Treatment Market Analysis in Surgery by Geography (USD MN)
Global Optic Nerve Disorder Treatment Market Analysis by Indication (USD MN)
Global Optic Nerve Disorder Treatment Market Analysis in Glaucoma by Geography (USD MN)
Global Optic Nerve Disorder Treatment Market Analysis in Optic Neuritis by Geography (USD MN)
Global Optic Nerve Disorder Treatment Market Analysis in Optic Neuropathy by Geography (USD MN)
Global Optic Nerve Disorder Treatment Market Analysis in Others by Geography (USD MN)
Global Optic Nerve Disorder Treatment Market Analysis by End User (USD MN)
Global Optic Nerve Disorder Treatment Market Analysis in Hospitals by Geography (USD MN)
Global Optic Nerve Disorder Treatment Market Analysis in Ambulatory Surgery Centers by Geography (USD MN)
Global Optic Nerve Disorder Treatment Market Analysis in Clinics by Geography (USD MN)
Global Optic Nerve Disorder Treatment Market Analysis in Others by Geography (USD MN)
Latin America Optic Nerve Disorder Treatment Market by Revenue
Middle East & Africa Optic Nerve Disorder Treatment Market by Revenue
Recent Development in Optic Nerve Disorder Treatment Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "